Dawn K. Schirm - Concepedia

Author

Dawn K. Schirm

University of Minnesota

Also Known As

D K Schirm, D.K. Schirm, Dawn K. Schirm, Dawn Schirm

Publications

890

Citations

H-Index

Concepts

All Affiliations

University of Minnesota University of Minnesota Medical Center

About

Dawn K. Schirm is an author at University of Minnesota specializing in cell biology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	378
2	Cell Biology	4	4	378
3	Immunology	3	3	361
4	Cellular Therapies	1	1	212
5	Pharmacology	1	1	17

Dawn K. Schirm

Publications

890

Citations

H-Index

Page 1

	Year	Citations
Massive ex Vivo Expansion of Human Natural Regulatory T Cells (T <sub>regs</sub> ) with Minimal Loss of in Vivo Functional Activity Keli L. Hippen, Sarah C. Merkel, Dawn K. Schirm, Science Translational Medicine	2011	355
Generation and Large-Scale Expansion of Human Inducible Regulatory T Cells That Suppress Graft-Versus-Host Disease Keli L. Hippen, Sarah C. Merkel, Dawn K. Schirm, American Journal of Transplantation Cell TherapyT-regulatory CellImmunologyImmune RegulationLarge-scale Expansion	2011	212
A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells Upasana Sunil Arvindam, P.M.M. van Hauten, Dawn K. Schirm, Leukemia Natural Killer CellsImmunologyAml CellsCell DeathImmunologic Mechanism	2020	102
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes Keli L. Hippen, Christoph Bucher, Dawn K. Schirm, Blood	2011	77
Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager Martin Felices, Todd Lenvik, Behiye Kodal, Cancer Immunology Research	2020	69
Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion Jacob A. Myers, Dawn K. Schirm, Laura E. Bendzick, JCI Insight ImmunologyCell DeathImmunologic MechanismImmunotherapyNatural Killer Cells	2022	47
Dinaciclib enhances natural killer cell cytotoxicity against acute myelogenous leukemia Hyun Don Yun, Dawn K. Schirm, Martin Felices, Blood Advances Hematological MalignancyTumor BiologyNk-cell ActivityMedicineApoptosis	2019	17
Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia Emily J. Pomeroy, Lindsey A. Lee, R D W Lee, Oncogene	2016	11

Page 1